| Neuro Health Pc | |
|
13620 38th Ave #5a Flushing NY 11354-4233 | |
| (646) 409-4402 | |
| (718) 841-7596 |
| Full Name | Neuro Health Pc |
|---|---|
| Speciality | Psychiatry & Neurology |
| Location | 13620 38th Ave, Flushing, New York |
| Authorized Official Name and Position | Charlotte Chiu (OFFICE MANAGER) |
| Authorized Official Contact | 6464094402 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Neuro Health Pc 12 Briarbrook Dr Briarcliff Manor NY 10510-2075 Ph: (646) 409-4402 | Neuro Health Pc 13620 38th Ave #5a Flushing NY 11354-4233 Ph: (646) 409-4402 |
| NPI Number | 1154563526 |
|---|---|
| Provider Enumeration Date | 04/01/2009 |
| Last Update Date | 04/01/2009 |
| Medicare PECOS PAC ID | 3476601543 |
|---|---|
| Medicare Enrollment ID | O20090429000137 |
News Archive
After more than 30 years of research and an extensive open-label weight loss study, WellWorld Science® announces the official U.S. launch of Livea®, a doctor-developed, non-prescription, patent-pending appetite-control supplement that is unlike any other dietary supplement on the market.
How can an active principle be delivered in a controlled way? Until now, there was no obvious answer to this question. Now however, researchers at the CNRS Paul Pascal Research Center in Bordeaux have designed smart capsules that are able to release their contents on demand, simply by raising the temperature. Described in an article published on 2 February 2010 in the journal Langmuir, this novel system has just been patented. It opens up the way to many applications in a large number of fields such as food, perfumes and agriculture, for instance to deliver pesticides above a specific temperature.
NeoMatrix, Inc., developers of the innovative HALO® Breast Pap Test, has been awarded a new technology agreement by Novation, the supply contracting company of VHA Inc, University HealthSystem Consortium (UHC) and Provista.
The U.S. Food and Drug Administration announced today actions to provide important information about the risks of using Essure and to help women and their doctors be better informed of the potential complications associated with implantable forms of sterilization.
Human Genome Sciences, Inc. today announced that it has received preliminary written feedback from the U.S. Food and Drug Administration (FDA) regarding the Company's Biologics License Application (BLA) seeking approval in the United States to market 900-mcg ZALBIN™ (albinterferon alfa-2b, known in Europe as JOULFERON®) dosed every two weeks for the treatment of chronic hepatitis C. FDA has expressed concerns regarding the risk benefit assessment of ZALBIN dosed at 900-mcg every two weeks.
› Verified 2 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1154563526 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084N0400X | Psychiatry & Neurology - Neurology | 225262 (New York) | Primary |
| Provider Name | Jyh-haur Lu |
|---|---|
| Provider Type | Practitioner - Neurology |
| Provider Identifiers | NPI Number: 1346313574 PECOS PAC ID: 1557351657 Enrollment ID: I20040512001018 |
News Archive
After more than 30 years of research and an extensive open-label weight loss study, WellWorld Science® announces the official U.S. launch of Livea®, a doctor-developed, non-prescription, patent-pending appetite-control supplement that is unlike any other dietary supplement on the market.
How can an active principle be delivered in a controlled way? Until now, there was no obvious answer to this question. Now however, researchers at the CNRS Paul Pascal Research Center in Bordeaux have designed smart capsules that are able to release their contents on demand, simply by raising the temperature. Described in an article published on 2 February 2010 in the journal Langmuir, this novel system has just been patented. It opens up the way to many applications in a large number of fields such as food, perfumes and agriculture, for instance to deliver pesticides above a specific temperature.
NeoMatrix, Inc., developers of the innovative HALO® Breast Pap Test, has been awarded a new technology agreement by Novation, the supply contracting company of VHA Inc, University HealthSystem Consortium (UHC) and Provista.
The U.S. Food and Drug Administration announced today actions to provide important information about the risks of using Essure and to help women and their doctors be better informed of the potential complications associated with implantable forms of sterilization.
Human Genome Sciences, Inc. today announced that it has received preliminary written feedback from the U.S. Food and Drug Administration (FDA) regarding the Company's Biologics License Application (BLA) seeking approval in the United States to market 900-mcg ZALBIN™ (albinterferon alfa-2b, known in Europe as JOULFERON®) dosed every two weeks for the treatment of chronic hepatitis C. FDA has expressed concerns regarding the risk benefit assessment of ZALBIN dosed at 900-mcg every two weeks.
› Verified 2 days ago
News Archive
After more than 30 years of research and an extensive open-label weight loss study, WellWorld Science® announces the official U.S. launch of Livea®, a doctor-developed, non-prescription, patent-pending appetite-control supplement that is unlike any other dietary supplement on the market.
How can an active principle be delivered in a controlled way? Until now, there was no obvious answer to this question. Now however, researchers at the CNRS Paul Pascal Research Center in Bordeaux have designed smart capsules that are able to release their contents on demand, simply by raising the temperature. Described in an article published on 2 February 2010 in the journal Langmuir, this novel system has just been patented. It opens up the way to many applications in a large number of fields such as food, perfumes and agriculture, for instance to deliver pesticides above a specific temperature.
NeoMatrix, Inc., developers of the innovative HALO® Breast Pap Test, has been awarded a new technology agreement by Novation, the supply contracting company of VHA Inc, University HealthSystem Consortium (UHC) and Provista.
The U.S. Food and Drug Administration announced today actions to provide important information about the risks of using Essure and to help women and their doctors be better informed of the potential complications associated with implantable forms of sterilization.
Human Genome Sciences, Inc. today announced that it has received preliminary written feedback from the U.S. Food and Drug Administration (FDA) regarding the Company's Biologics License Application (BLA) seeking approval in the United States to market 900-mcg ZALBIN™ (albinterferon alfa-2b, known in Europe as JOULFERON®) dosed every two weeks for the treatment of chronic hepatitis C. FDA has expressed concerns regarding the risk benefit assessment of ZALBIN dosed at 900-mcg every two weeks.
› Verified 2 days ago
Rvc Medical Consultation Pc Mental Health Clinic Medicare: Medicare Enrolled Practice Location: 14227 Franklin Ave, Flushing, NY 11355 Phone: 718-964-3007 Fax: 718-395-3007 | |
R Jacobs Csw Counseling Services Pc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 43 40 Union St, Apt 1k, Flushing, NY 11355 Phone: 718-463-1539 | |
Prime Time Care, Inc. Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 13844 Jewel Ave, Flushing, NY 11367 Phone: 718-263-3455 Fax: 718-263-2340 | |
Sarang Medical, P.c. Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 13620 38th Ave, Suite 3a-1, Flushing, NY 11354 Phone: 347-886-0809 | |
Flushing Neurology Services, P.c. Mental Health Clinic Medicare: Medicare Enrolled Practice Location: 13620 38th Ave Ste 6g, Flushing, NY 11354 Phone: 718-888-0968 Fax: 718-888-1506 | |
Asian Alcoholism (2) Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 14015b Sanford Ave, Flushing, NY 11355 Phone: 718-358-8288 Fax: 718-358-5265 | |
Asian Clinic (2) Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 14015b Sanford Ave, Flushing, NY 11355 Phone: 718-358-8288 Fax: 718-358-5265 |